FDA approves gene therapy to treat adult lymphoma – Tribune-Review
|
FDA approves gene therapy to treat adult lymphoma
Tribune-Review On Wednesday, Oct. 18, 2017, the Food and Drug Administration approved sales of the therapy Yescarta, developed by Kite Pharma. It is the second gene therapy for U.S. patients _ the first one for adults _ a custom-made, one-time treatment for certain … |
